MyFinsight
Home
About
Contact
isco: the income statement
Download
Download image
Anti Aging Market
$0.165M
Biomedical Market
$2.204M
Product sales
$2.369M
(8.72%↑ Y/Y)
Income (loss) from
operations
$0.094M
(204.44%↑ Y/Y)
Total operating
expenses
$2.275M
(0.26%↑ Y/Y)
Net income (loss)
$0.057M
(145.60%↑ Y/Y)
Total other expense,
net
-$0.037M
(-5.71%↓ Y/Y)
Research and development
$0.158M
(-15.51%↓ Y/Y)
Selling and marketing
$0.28M
(-4.11%↓ Y/Y)
General and
administrative
$0.789M
(-3.31%↓ Y/Y)
Cost of sales
$1.048M
(7.60%↑ Y/Y)
Net income (loss)
attributable to common...
$0.029M
(123.20%↑ Y/Y)
Undistributed earnings
allocated to...
$0.028M
Interest expense -
related party
$0.036M
Interest expense
$0.001M
(-97.14%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)